Neuromodulation Focus Northstar has developed the Renova Cortical Stimulation System that delivers targeted electrical stimulation to the cerebral cortex, positioning the company to partner with neurology and neurosurgery centers for adoption in neuromodulation therapies across neurological diseases and disorders.

Small Team Advantage A lean team enables streamlined partnerships with larger medical device players for distribution, manufacturing support, or licensing to accelerate market entry and scale.

US Market Potential With United States focus and revenue in the low to mid seven figures, target hospitals, specialty clinics, and device manufacturers to expand adoption of cortical stimulation within neuromodulation portfolios.

Competitive Positioning Operate in a competitive neuromodulation landscape; differentiate with cortex specific stimulation and robust clinical data to support faster adoption through partnerships with established device companies.

Growth Partnerships Explore strategic collaborations for clinical development, regulatory navigation, and geographic expansion to scale the Renova platform through licensing or distribution deals.